Top Markets
Coin of the day
Xspray Pharma AB (publ) Xspray Pharma AB (publ)

Xspray Pharma AB (publ)

XSPRAY
Pozycja w akcjach #24929
Xspray Pharma AB (publ), a pharmaceutical firm based in Solna, Sweden,... Xspray Pharma AB (publ), a pharmaceutical firm based in Solna, Sweden, specializes in developing protein kinase inhibitors for precise cancer treatments. Their current drug pipeline includes HyNap-Nilo, aimed at chronic myeloid leukemia; HyNap-Sora, which targets renal, liver, and several types of thyroid cancer; and HyNap-Dasa, intended for both chronic myeloid leukemia and acute lymphoblastic leukemia. Established in 2003, the company was formerly known as Xspray Microparticles AB until its name change to Xspray Pharma AB (publ) in 2017.
Cena akcji
$1.17
Kapitalizacja rynkowa
$55.29M
Zmiana (1 dzień)
0.38%
Zmiana (1 rok)
-73.61%
Kraj
SE
Handel Xspray Pharma AB (publ) (XSPRAY)

Kategoria

Historia stopy dywidendy dla Xspray Pharma AB (publ) (XSPRAY)
Stopa dywidendy (TTM) dla Xspray Pharma AB (publ) (symbol akcji: XSPRAY) na dzień 2026 wynosi: 0
Średnia stopa dywidendy z ostatnich 5 lat: 0.00%
Historia stopy dywidendy dla Xspray Pharma AB (publ) (XSPRAY) od 2026 do 2026
Stopa dywidendy na koniec każdego roku (TTM)
Rok Stopa dywidendy Zmień
Za mało danych dla podanych dat.
Stopy dywidendy (TTM) dla podobnych firm lub konkurencji